| Overall | Full standard protocol | Partially adapted protocol: admission only | Partially adapted protocol: admission + dosing | Fully adapted protocol |
---|---|---|---|---|---|
# of sites | 61 | 58 | 17 | 28 | 34 |
# of records | N = 21,860 | n = 10,006 | n = 4290 | n = 4128 | n = 3436 |
 | Point (95 CI) | Point (95 CI) | Point (95 CI) | Point (95 CI) | Point (95 CI) | p-value |
---|---|---|---|---|---|---|
Age at enrollment (months) | n = 21,770 | n = 9936 | n = 4290 | n = 4127 | n = 3417 |  |
 Median (range) | 15 (1.0–59.0) | 15 (1.0–59.0) | 18 (6.0–59.0) | 13 (1.0–58.0) | 14 (6.0–59.0) |  < 0.001 |
 Mean (CI) | 17.8 (17.6–17.9) | 18.1 (17.9–18.3) | 19.5 (19.2–19.9) | 15.8 (15.5–16.0) | 17.1 (16.8–17.4) | |
 6–12 months | 42.3% (41.7–43.0%) | 42.5% (41.6–43.5%) | 35.2% (33.8–36.6%) | 47.5% (45.9–49.0%) | 44.5% (42.8–46.2%) |  < 0.001 |
 13–24 months | 37.5% (36.9–38.1%) | 35.8% (34.9–36.7%) | 38.8% (37.3–40.2%) | 41.4% (39.8–42.9%) | 36.2% (34.6–37.8%) | |
 25–36 months | 15.2% (14.7–15.6%) | 16.2% (15.5–16.9%) | 19.3% (18.1–20.5%) | 8.7% (7.8–9.6%) | 14.7% (13.5–15.9%) | |
 37–48 months | 4.3% (4.0–4.6%) | 4.5% (4.1–4.9%) | 5.9% (5.2–6.6%) | 2.3% (1.8–2.8%) | 4.2% (3.6–4.9%) | |
 49–59 months | 0.7% (0.6–0.8%) | 1.0% (0.8–1.2%) | 0.8% (0.6–1.1%) | 0.2% (0.0–0.3%) | 0.4% (0.2–0.6%) | |
Sex | n = 21,823 | n = 10,003 | n = 4289 | n = 4117 | n = 3414 |  |
 Female | 54.8% (54.1–55.4%) | 54.9% (53.9–55.8%) | 54.3% (52.8–55.8%) | 55.4% (53.8–56.9%) | 54.3% (52.7–56.0%) | 0.744 |
 Male | 45.2% (44.6–45.9%) | 45.1% (44.2–46.1%) | 45.7% (44.2–47.2%) | 44.6% (43.1–46.2%) | 45.7% (44.0–47.3%) | |
MUAC at Enrollment (mm) | n = 21,812 | n = 9961 | n = 4288 | n = 4128 | n = 3435 |  |
 Median (range) | 112 (70.0–135.0) | 112 (70.0–125.0) | 112 (71.0–135.0) | 112 (83.0–114.0) | 112 (84.0–114.0) |  < 0.001 |
 Mean (CI) | 111.2 (111.1–111.2) | 111.0 (110.9–111.0) | 111.1 (111.0–111.3) | 111.3 (111.2–111.4) | 111.6 (111.5–111.7) | |
Change in MUAC from Enrollment to Discharge (mm) | n = 21,798 | n = 9954 | n = 4284 | n = 4125 | n = 3435 |  |
 Median (range) | 6 (− 43.0–46.0) | 6 (− 43.0–46.0) | 7 (− 22.0–45.0) | 5 (− 28.0–41.0) | 5 (− 21.0–33.0) |  < 0.001 |
 Mean (CI) | 6.3 (6.2–6.3) | 6.4 (6.3–6.4) | 7.0 (6.9–7.1) | 6.1 (6.0–6.2) | 5.4 (5.3–5.6) | |
Length of stay | n = 18,370 | n = 7332 | n = 4263 | n = 3974 | n = 2801 |  |
 Median (IQR) | 49 (34.0–67.0) | 53 (36.0–70.0) | 42 (28.0–62.0) | 43 (32.0–59.0) | 47 (35.0–70.0) |  < 0.001 |
 Mean (CI) | 51.0 (50.7–51.4) | 55.3 (54.8–55.9) | 45.3 (44.6–46.0) | 48.0 (47.3–48.7) | 52.7 (51.8–53.7) | |
Time to recovery* | n = 16,757 | n = 6569 | n = 3677 | n = 3839 | n = 2672 |  |
 Median (IQR) | 49 (35.0–64.0) | 53 (37.0–70.0) | 42 (28.0–58.0) | 42 (32.0–58.0) | 47 (35.0–70.0) |  < 0.001 |
 Mean (CI) | 51.1 (50.7–51.4) | 55.5 (54.9–56.1) | 45.2 (44.5–45.9) | 47.8 (47.1–48.5) | 52.9 (51.9–53.8) | |
Exit type | n = 21,860 | n = 10,006 | n = 4290 | n = 4128 | n = 3436 |  |
 Cured | 90.3% (89.9–90.6%) | 88.0% (87.4–88.7%) | 85.9% (84.9–87.0%) | 95.8% (95.2–96.4%) | 95.5% (94.8–96.2%) |  < 0.001 |
 Default | 1.8% (1.6–2.0%) | 2.5% (2.2–2.8%) | 2.2% (1.8–2.6%) | 0.4% (0.2–0.5%) | 1.1% (0.8–1.5%) | |
 Death | 0.1% (0.0–0.1%) | 0.0% (0.0–0.1%) | 0.1% (0.0–0.3%) | 0.0% (0.0–0.0%) | 0.0% (0.0–0.0%) | |
 Non-response | 2.2% (2.0–2.4%) | 2.5% (2.2–2.8%) | 4.0% (3.4–4.6%) | 1.1% (0.8–1.5%) | 0.3% (0.1–0.5%) | |
 Not recovered/ outcome unknown | 3.2% (3.0–3.4%) | 4.4% (4.0–4.8%) | 1.6% (1.2–2.0%) | 2.6% (2.1–3.1%) | 2.4% (1.9–2.9%) | |
 Transfer | 2.5% (2.3–2.7%) | 2.5% (2.2–2.8%) | 6.1% (5.4–6.8%) | 0.1% (0.0–0.2%) | 0.7% (0.4–1.0%) |